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A B S T R A C T
Cystic ﬁbrosis (CF) is caused by mutations in the gene encoding the CFTR anion channel. Loss of CFTR function
in pancreatic, biliary and intestinal epithelia, severely aﬀects gastrointestinal function. Transcriptome analysis
indicated the activation of an innate and adaptive immune response in the distal small intestine of Cftr null mice.
Inﬂammation was associated with diﬀerential regulation of numerous genes involved in the transport and
metabolism of nutrients and, particularly, lipids, that are targeted by ligand-dependent nuclear receptors and/or
HNF4α. Among the most strongly down-regulated genes are the FXR targets Fgf15 and Nr0b2, the PPARα target
Pdk4, and the PXR target Ces2a, whereas expression of the CF modiﬁer gene Slc6a14 was strongly increased.
Most changes in gene expression were reversed by bacterial containment. Our data suggest that the gut mi-
crobiota has a pervasive eﬀect on gene expression in CF mice, aﬀecting enterocyte maturation, lipid metabolism,
and nutrient absorption in CF.
1. Introduction
Cystic ﬁbrosis (CF) is a potentially lethal disease that is caused by
mutations in the CF transmembrane conductance regulator (CFTR)
gene, which encodes a phosphorylation-regulated chloride/bicarbonate
channel that drives salt and water secretion across various epithelia,
foremost those in the respiratory and the gastrointestinal tract. CFTR-
mediated anion secretion contributes to bile formation, and is critical
for exocrine pancreatic function and for salt and water secretion across
the intestinal epithelium. Thus, the intestinal pathology of CF is char-
acterized by luminal dehydration, luminal surface acidiﬁcation and
accretion of viscous mucus [1]. Mucus accumulation and dehydration
are thought to play a key role in the development of the CF-typical
obstruction of the distal small intestine. The abnormally viscous mucus
layer that lines the epithelium may also provide a niche for bacterial
colonization, leading to small intestinal bacterial overgrowth (SIBO)
[2]. SIBO is relatively common among CF patients and may aﬀect the
luminal processing and uptake of nutrients (lipids in particular) and
bile acids, potentially contributing to their malabsorption and to the
growth retardation observed in CF. SIBO is likely to markedly impact
host-microbe interactions, and trigger a local, innate immune response
[2]. This is most evident from studies on CF mouse models, which re-
port evidence for both SIBO and inﬂammation of the gut wall [3,4].
A limited number of studies have systematically assessed the eﬀect
of the CF condition on intestinal gene expression, using a DNA micro-
array approach [3,5–7]. Applied to a Cftr null mouse model with a se-
vere intestinal phenotype (i.e. a strong predisposition to develop a le-
thal obstruction in early life), these microarray studies have shown that
CF is associated with marked changes in intestinal gene expression.
Some of these changes appear to be directly related to SIBO, e.g. the up-
regulation of genes involved in host-microbe interactions [3]. For other
diﬀerentially regulated genes this link with SIBO is less evident. For
instance, it was shown that the expression of peroxisome proliferator
activated receptor γ (PPARγ) targets is reduced in the CF intestine,
conceivably because of a shortage of activating ligands [7]. Also, it was
shown that antibiotic treatment did not restore expression of genes
involved in the processing/uptake of macro- and micro-nutrients, al-
though it did improve weight gain [4,6].
These studies assessing the CF intestinal transcriptome have yielded
important insights into the pathophysiology of CF-related intestinal
disease. However, one limitation is that they were performed on ani-
mals reared on a lipid-enriched, low-carbohydrate/protein elemental
liquid diet (Peptamen), which may have intrinsic eﬀects on the CF
gastrointestinal phenotype and the gut microbiota [8,9]. Also, only one
of these studies speciﬁcally addressed gene expression in the distal
small intestine, i.e. the region which is most susceptible to obstruction
and SIBO, and has a key role in bile acid uptake [5]. In the present
study, to exclude confounding eﬀects of the dietary regimen, we
https://doi.org/10.1016/j.ygeno.2019.06.028
Received 17 May 2019; Received in revised form 18 June 2019
⁎ Corresponding author.
E-mail address: m.bijvelds@erasmusmc.nl (M.J.C. Bijvelds).
Genomics xxx (xxxx) xxx–xxx
0888-7543/ © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Please cite this article as: Pauline T. Ikpa, et al., Genomics, https://doi.org/10.1016/j.ygeno.2019.06.028
assessed the ileal transcriptome of CF mice reared on a solid diet with a
standard nutrient formulation. The CF mouse model used by us diﬀers
from the one presented in previous CF-related microarray analyses in
that, probably because of secondary genetic and environmental factors,
it does rarely suﬀer lethal intestinal obstructions in the adult stage,
even when maintained on a conventional regimen (i.e. a solid chow and
drinking water without added osmolytes). We employed a next-gen-
eration sequencing technique, RNAseq, that allows the quantiﬁcation of
RNA transcripts with single base-pair resolution, while maintaining a
high dynamic detection range. To minimize variation in gene expres-
sion resulting from secondary genetic and environmental factors, we
used sex (and age) matched littermate couples that, from birth onwards,
were housed together. Recent advancements in the analysis of high-
throughput gene expression data, speciﬁcally the application of algo-
rithms that assess causal networks that are assimilated based on prior
published research, enabled us to identify diﬀerentially regulated sig-
naling pathways and their upstream modulators [10,11].
2. Materials and methods
2.1. Animal procedures and tissue collection
CF (Cftr−/−) mice (Cftrtm1Cam; congenic FVB/n) and littermate
controls (Cftr N/N) were obtained from a colony that was maintained
by continual (> 20 generations) crossing of the heterozygous progeny.
This colony was kept at an environmentally controlled facility at the
Erasmus University Medical Center (microbial status: SPF; 12 h light/
12 h dark cycle, 20–22 °C). CF/wildtype, sex-matched littermate cou-
ples were housed together in individually ventilated cages, and were
reared on a low ﬁber diet (C1013; protein: 17.6%, fat: 5.1%, carbo-
hydrates: 62.2%; Altromin) and a polyethylene glycol/electrolyte
drinking solution to prevent intestinal obstruction in early life [12]. For
transcriptome analysis, four such littermate couples were used (3F/
1M), of which one couple (F) was administered drinking water sup-
plemented with ciproﬂoxacin (0.3 g/L) and metronidazole (0.5 g/L) for
15 days [13]. Before tissue collection, animals were kept on normal
drinking water (or, when applicable, drinking water supplemented with
antibiotics) for ≥4 days. This procedure is well tolerated by the adult
CF mice used presently for tissue collection (age: 12–17weeks; body
mass: 21–25 g), and none of the animals used showed signs of (im-
minent) intestinal obstruction. Behavior (e.g. gait, activity) preceding
termination was normal, intake of food and water during this period
was comparable between genotypes (not shown), and, when animals
were sacriﬁced, the small intestine did not contain inspissated material.
Experiments were approved of by the Independent Committee on
Ethical Use of Experimental Animals, Rotterdam, according to national
guidelines (141-1208; 120-0501/0902).
2.2. RNA isolation
Animals were anaesthetized (ketamine 120mg/kg, xylazine 20mg/
kg; i.p.), and the intestinal tract was collected and ﬂushed with ice-cold
saline. Ileal sections (3–5mm in length) were collected at 5–6 cm
proximal to the ileocecal valve. Sampling from a CF animal (Cftr−/−)
and a sex-matched littermate control (Cftr N/N) was performed within a
time window of 20min, and between 12:00–14:00 h, to control for
diurnal variations in gene expression. Tissue was homogenized with a
rotor-stator homogenizer in Trizol reagent (Qiagen), and total RNA was
extracted using the Nucleospin RNA kit (Macherey-Nagel). The in-
tegrity of the extracted RNA was veriﬁed by gel electrophoresis.
2.3. Transcriptome sequencing
Transcriptome sequencing was performed at the Beijing Genomics
Institute (BGI). In brief, after RNA integrity was veriﬁed (RIN > 9.0;
Agilent 2100 Bioanalyzer), mRNA (200 ng) was isolated from total RNA
(Truseq RNA sample preparation kit; Illumina), fragmented and sub-
sequently used for cDNA synthesis (Superscript II cDNA synthesis kit;
Invitrogen). End-repaired cDNA was puriﬁed (Agencourt Ampure XP
beads; Beckman Coulter) and ampliﬁed by PCR. The resulting cDNA
library was sequenced using an HiSeq 2000 sequencer and TruSeq SBS
Kit v3-HS reagent kit (Illumina). Data were processed with CLC
genomic workbench 7.5 (CLC Bio), and the sequence reads were
mapped to the Genome Reference Consortium (GRC) genome data set
GRCm38.76, using default parameters. Data depict reads per 1000 base
pair transcript per million reads mapped (RPKM). Datasets are available
through the NCBI-GEO repository (GSE92991).
2.4. Data analysis
Transcriptome data were analyzed using the Ingenuity® web-based
software application (Version 1.10; Qiagen). Ingenuity pathway ana-
lysis (IPA) and upstream regulator analysis (URA) was applied to
identify diﬀerentially regulated pathways and their upstream mod-
ulators, as described in detail elsewhere [10]. The enrichment of the
dataset with up- or down-regulated genes comprised within a signal
transduction network was assessed using Fisher's exact test (overlap P-
value). To assess the activation state of a pathway and its upstream
regulator, the consistency of the match between the observed and the
predicted (based on established interactions within a network) ex-
pression pattern was calculated (activation Z-score). A positive Z-score
signiﬁes a regulator in the active state, a negative score indicates that
its activity is repressed.
The gene set enrichment analysis (GSEA; Broad Institute) software
platform (MSigDB version 6.1) was used to compare the observed ex-
pression proﬁles to a priori deﬁned gene sets which represent well-
deﬁned biological processes (Hallmark and KEGG curated gene sets;
Molecular Signatures database; Broad Institute) [14]. The degree to
which genes in the predeﬁned set are overrepresented at the extremes
of the ranked list of transcripts in the sample is reﬂected by the en-
richment score, as described in detail elsewhere [11]. After enrichment
scores were normalized to allow for diﬀerences in gene set size, they
were statistically evaluated using a correction for multiple hypotheses
testing. The reported false discovery rate (FDR) is the estimated prob-
ability that the observed normalized enrichment score (NES) constitutes
a false positive result.
For identiﬁcation of diﬀerentially regulated canonical signaling
pathways in the ileum of CF mice (Cftr−/−), compared to controls
(Cftr N/N), transcriptome data from 3 littermate couples (2F/1M) were
used. For IPA, for each couple and transcript, expression in the CF
animal was calculated relative to the respective control. Identiﬁcation
of diﬀerentially regulated signaling pathways was based on 2644 genes
that were up- or down-regulated by a factor of> 1.25 in all couples. To
assess the eﬀect of the antibiotic treatment on ileal gene expression, for
each genotype, the expression in one treated animal was expressed
relative to the average expression level in the untreated animals. This
analysis was performed on the 3937 and 2062 genes that were diﬀer-
entially regulated by a factor of> 1.5 in CF mice and controls, re-
spectively. To minimize the contribution of genes with negligible ex-
pression, only genes expressed at> 1 RPKM in the conventionally
reared group qualiﬁed for inclusion in the set of down-regulated genes,
whereas only genes expressed at> 1 RPKM after antibiotic treatment
were eligible for inclusion in the set of up-regulated genes. For GSEA,
no prior selection was made and the analysis was based on the entire
expression data set.
3. Results
3.1. Activation of the innate and adaptive immune response in the CF ileum
IPA employs prior knowledge of cause-eﬀect relationships in sig-
naling networks to interpret gene-expression datasets, providing
P.T. Ikpa, et al. Genomics xxx (xxxx) xxx–xxx
2
(caption on next page)
P.T. Ikpa, et al. Genomics xxx (xxxx) xxx–xxx
3
information on the direction of regulation of such signaling networks.
We compared the ileal transcriptome of CF mice and wildtype litter-
mates by IPA. This identiﬁed numerous diﬀerentially regulated cano-
nical signaling pathways. The most aﬀected canonical pathways (based
on the overlap P-value) represent immunological responses and path-
ways involved in lipid metabolism that are regulated by ligand-de-
pendent nuclear receptors (Fig. 1A). Many of the up-regulated genes
comprised in these partially overlapping pathways encode proteins
involved in antigen processing or (co-)receptors and ligands that form
the immunological synapse between antigen-presenting and CD4+
cells (Table S1). This includes molecules involved in antigen association
with MHC molecules and their presentation to the T cell receptor (TCR)
complex, several (co-)receptors and cytokines that stimulate diﬀer-
entiation of naïve CD4+ cells into T helper cells, and the iCOSL-iCOS
(inducible T-cell co-stimulator ligand/receptor) signaling axis, which
contributes to the regulation of activated T cells. In line with T helper
cell activation, many genes involved in B cell development were also
up-regulated.
GSEA evaluates transcriptome data in the context of predeﬁned
gene sets, which are compiled on the basis of previous gene expression
analyses. We used it as an independent platform to validate the IPA.
Congruent with IPA, GSEA indicated that the hallmark inﬂammatory
response gene set, and the KEGG gene sets representing antigen pro-
cessing and presentation, and T cell receptor signaling were up-regu-
lated in CF (Fig. 1B–D). Collectively, these data point towards the ac-
tivation of an innate and adaptive immune response and the
recruitment of immune cells in the CF gut.
URA employs prior knowledge of the interactions within signaling
cascades to identify molecules that potentially cause the changes in
gene expression observed in the data set [10]. Testament to its ability to
correctly infer such underlying causes, URA identiﬁed CFTR as an up-
stream regulator that is in an inhibited state in the CF ileum (Table 1).
URA indicated that the CF intestinal gene expression proﬁle is most
consistent with enhanced exposure to bacterial lipopolysaccharide
(LPS). Further, URA identiﬁed molecules operating downstream of LPS,
like the Toll-like receptor (TLR4) and the T cell receptor complex
(TCR), pro-inﬂammatory transcription factors (nuclear factor κB, NFκB;
signal transducer and activator of transcription, STAT1), and pro-in-
ﬂammatory cytokines, including IFNγ, IL-1β, IL2, IL-6 and TNFα. The
transcription regulator c-Myc and cytokines such as CSF and HGF are
involved in cell cycle progression and cellular transformation. Apart
from CFTR, among the most signiﬁcantly inactivated molecules iden-
tiﬁed by the URA are the anti-inﬂammatory IL-10 receptor and the
PPARα/γ nuclear receptors (see below).
GSEA mirrored these ﬁndings, showing up-regulation of gene sets
marking TLR, IFNα, IFNγ, IL2-STAT5, IL6-JAK-STAT3, TNFα-NFκB
signaling, and hematopoietic cell development (Table 2). It also showed
activation of the hallmark c-Myc and E2F targets gene sets in the CF
ileum. The activation of c-Myc and E2F-type transcription factors may
reﬂect proliferation of lymphoid and myeloid lineages, but can also
point towards enhanced proliferation of epithelial cells [15].
3.2. LPS represses the activity of type II ligand-dependent nuclear receptors
in the CF ileum
The IPA indicated that the release of LPS and IL-1β inhibits the
activity of the retinoid X receptors (RXRα/β) in the CF ileum (Fig. 1A;
Table S1). Previous studies have shown that LPS leads to
transrepression of RXRα and reduces its nuclear localization in hepa-
tocytes [16–18]. Because the RXRs form obligate heterodimers with
type II ligand-dependent nuclear receptors, including the farnesoid X
receptor (FXR; NR1H4), the liver X receptor (LXR; NR1H2/3), the
Fig. 1. Diﬀerential regulation of canonical signal transduction pathways in the murine CF ileum. A. IPA was used to assess the enrichment of the dataset with up- or
down-regulated genes that make up predeﬁned signal transduction networks. Depicted are the 15 canonical pathways with the lowest overlap P-value. Bars are
colored to indicate the activation Z-score of the pathway. Gray bars indicate pathways that are ineligible for a prediction. B. Heat map depicting relative transcript
levels of genes comprised in the GSEA hallmark inﬂammatory response set, in CF (−/−) and wildtype (N/N) mice. Gene symbols refer to the human orthologues. C.
Corresponding enrichment plot of the hallmark inﬂammatory response gene set. D. Enrichment plots of the KEGG antigen processing and presentation, and T cell
receptor signaling gene sets.
Table 1
URA of the CF ileum. URA was applied to assess the activation state of mole-
cules that potentially cause the changes in gene expression observed in the data
set. Depicted are molecules with |Z-score| > 4.
Molecule Category Z-score −log(overlap P-
value)
Activated in CF
TNF Cytokine 8.75 35.3
lipopolysaccharide Toxicant 8.16 45.2
IFNG Cytokine 7.51 33.4
CSF2 Cytokine 7.07 18.6
E. coli B5
lipopolysaccharide
Toxicant 6.30 9.7
IL1B Cytokine 6.24 22.4
CD28 Transmembrane
receptor
5.61 5.3
CD3 Complex 5.61 13.8
E. coli B4
lipopolysaccharide
Toxicant 5.41 11.9
IL6 Cytokine 5.39 26.7
CD40LG Cytokine 5.28 12.4
IL5 Cytokine 5.20 17.2
CD38 Enzyme 5.15 11.8
IL2 Cytokine 5.12 12.5
IL1A Cytokine 5.11 3.5
ERBB2 Kinase 4.63 22.1
IL27 Cytokine 4.61 6.3
NFkB (complex) Complex 4.59 10.7
RELA Transcription
regulator
4.49 12.3
IL3 Cytokine 4.46 12.2
STAT1 Transcription
regulator
4.45 20.5
IL15 Cytokine 4.41 13.7
HGF Growth factor 4.25 14.4
TLR4 Transmembrane
receptor
4.17 8.7
MYC Transcription
regulator
4.16 19.3
PDGF BB Complex 4.15 12.3
IL1 Group 4.12 6.2
Interferon alpha Group 4.12 10.1
CSF1 Cytokine 4.09 7.1
IL4 Cytokine 4.08 21.6
F2 Peptidase 4.06 8.1
TCR Complex 4.04 12.7
CCND1 Transcription
regulator
4.04 3.4
OSM Cytokine 4.02 13.3
Inactivated in CF
IL10RA Transmembrane
receptor
−8.97 39.9
CFTR Ion channel −6.30 32.1
PPARA Ligand-dependent
NR
−5.57 40.2
POR Enzyme −5.11 28.2
PPARGC1A Transcription
regulator
−5.04 6.9
PPARG Ligand-dependent
NR
−4.49 22.7
RICTOR Other −4.47 3.1
let-7 Microrna −4.09 10.3
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pregnane X receptor (PXR; NR1I2) and PPARα/δ/γ, this markedly af-
fects the hepatic expression of genes involved in carbohydrate and lipid
metabolism. Several of the top canonical pathways identiﬁed by IPA are
linked to these functions (Fig. 1A). In the CF ileum, among the most
strongly down-regulated genes are the PXR-induced carboxylesterase
Ces2a (CES-), the FXR targets Fgf15 (human orthologue: FGF19) and
Nr0b2, involved in intestinal bile acid transport and hepatic bile acid
synthesis, and the PPARα target Pdk4, which encodes a pyruvate de-
hydrogenase kinase that, by repression of the pyruvate dehydrogenase
complex, restricts glycolysis and enhances fatty acid oxidation (Fig. 2A)
[19]. The set of RXRα/β-controlled genes identiﬁed by IPA further in-
cludes members of the ATP binding cassette family (Abca1, Abcb1a,
Abcg5, Abcg8), which encode proteins that facilitate transport of sterols
and xenobiotics to the intestinal lumen, and the fatty acid binding
proteins involved in the transport of bile acids and fatty acids
[17,20–22]. Also down-regulated are genes of the aldehyde dehy-
drogenase, and the cytochrome P450 and the ﬂavin-containing mono-
oxygenase families, involved in xenobiotic and lipid metabolism. GSEA
corroborated these ﬁndings, demonstrating down-regulation of the
hallmark gene sets representing bile acid, fatty acid and xenobiotic
metabolism (Fig. 2B).
3.3. Diﬀerential regulation of genes involved in intestinal barrier function
Inﬂammation of the gut wall has been shown to increase both the
permeability of the paracellular route to ions and water and to aﬀect
active, transcellular transport of solutes across the epithelium [23–25].
Table 2
GSEA of CF ileum. Enrichment scores of hallmark and KEGG gene sets re-
presenting pathways involved in cell cycle control and immunity.
Gene set Size NES FDR
Hallmark Myc targets v1 190 3.04 < 0.001
Hallmark E2F targets 181 3.02 < 0.001
Hallmark IFNγ response 170 2.95 < 0.001
Hallmark Myc targets v2 56 2.56 < 0.001
Hallmark IL6-Jak-Stat3 signaling 63 2.52 < 0.001
KEGG Hematopoietic cell lineage 49 2.38 < 0.001
Hallmark IFNα response 81 2.21 < 0.001
KEGG Toll-like receptor signaling 68 2.05 < 0.001
Hallmark TNFα signaling via NFκB 152 1.83 0.002
Hallmark IL2-Stat5 signaling 150 1.82 0.002
Fig. 2. Impaired type II ligand-dependent nuclear receptor function. A. Transcript levels of IPA-deﬁned genes that are regulated by type II ligand-dependent nuclear
receptors and involved in the metabolism and transport of fatty acids, sterols, bile acids and xenobiotics. Gene symbols refer to the human orthologues. $:< 1 RPKM.
Data shown are mean ± SE of 3 animals per group (2F/1M). B. Enrichment plots of gene sets representing bile acid, fatty acid and xenobiotic metabolism.
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Inﬂammation modulates the expression and localization of proteins that
form the tight junctions, and is typically associated with up-regulation
of the pore-forming claudin-2, whereas the expression of barrier-
forming claudins is reduced [23]. Correspondingly, in CF mice, it was
shown previously that small intestinal expression of Cldn2 was in-
creased, whereas the expression of some barrier-forming claudins
(Cldn1, Cldn8) was reduced [26]. However, it has also been argued that,
in CF patients, paracellular chloride absorption in the jejunum is re-
duced, which implies a reduction in chloride permeability of the tight
junctions [27].
Presently, IPA did not signal overt barrier dysfunction in CF mice,
but GSEA did indicate diﬀerential expression of genes in the hallmark
Fig. 3. Diﬀerential regulation of genes involved in intestinal barrier function. A. Heat map depicting relative transcript levels of genes comprised in the GSEA
hallmark apical junction set, in CF (−/−) and wildtype (N/N) mice. B. Enrichment plot of the gene set representing the apical junction complex. C. Transcript levels
of genes that encode proteins that make up the tight junctions and are expressed at> 1 RPKM. Data shown are mean ± SE of 3 animals per group (2F/
1M).*P < .05; **P < .01 (Paired t-test). Gene symbols refer to the human orthologues.
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set that represents the apical junction complex (Fig. 3A, B). However,
the leading edge of the enrichment plot contained numerous genes
involved in the formation of focal adhesions, which are not restricted to
epithelia (e.g. Itga9, Pkd1, Sgce, Vcl, Zyx), and the diﬀerential regulation
of these genes may point to remodeling of non-epithelial tissues.
Nevertheless, the set also included genes encoding bona ﬁde epithelial
markers, like Cldn8 and Tjp1 (ZO-1). Transcript levels of Cldn8, which is
expressed at comparatively low levels in the ileum, were lowered circa
5-fold in the CF ileum, compared to controls, whereas transcript levels
of the barrier-forming Cldn3 were marginally (< 1.5-fold), albeit con-
sistently, reduced (Fig. 3C). We observed a modest increase (ca. 1.5-
fold) in Cldn2 transcript levels in only two out of the three couples
analyzed. Transcript levels of the other major cation-selective pore-
forming claudin, Cldn15, which serves as a sodium shunt required for
the operation of sodium-coupled solute transporters, was unaﬀected
[28]. Next to the claudins, occludin (Ocln), tricellulin (Marveld2) and
marvelD3 (Marveld3) form a distinct family of tight junction proteins. In
CF ileum, trancript levels of Ocln were marginally reduced (< 1.5-fold),
whereas levels of Marveld3 were increased circa 1.5-fold. Marveld2
transcript levels were not aﬀected. Also, transcript levels of genes en-
coding proteases involved in the dynamic regulation of intercellular
junctions (Adam19, St14, Ctsk, F11r) were similar between genotypes
(not shown). However, we did observe a consistent reduction (> 2-fold
in all 3 couples) in Wnk4 transcript levels in the CF ileum (1.3 ± 0.3
vs. 2.8 ± 0.6 RPKM in CF and control mice, respectively; P < .01,
N=3). In renal epithelia, this protein kinase is localized to tight
junctions and its activation enhances paracellular chloride perme-
ability, conceivably through phosphorylation of speciﬁc claudins that
form anion-selective pores [29,30].
3.4. CF is associated with down-regulation of genes involved in the
absorption of monosaccharides, amino acids and B vitamins
Apart from a reduced activity of ligand-dependent nuclear receptors
that form heterodimers with RXRα/β, URA signaled a marked in-
activation of the transcription factor hepatocyte nuclear factor 4α
(HNF4α; Z-score: −3.76, overlap P-value: 1.13·10−17). In the liver,
HNF4α controls many genes involved in glucose and lipid metabolism,
in part through crosstalk with ligand-dependent nuclear receptors such
as PPARα. In the intestine, HNF4α function is associated with en-
terocyte maturation as many of the genes induced by HNF4α are in-
volved in nutrient absorption and processing [15,31,32]. Thus, the set
of established intestinal HNF4α targets includes genes involved in lipid
metabolism also targeted by type II ligand-dependent nuclear receptors
(Apoa4, Fabp1), as well as genes encoding brush border ectoenzymes
such as alkaline phosphatase (Alpi), alanyl aminopeptidase (Anpep),
lactase (Lct), meprin 1 (Mep1a) and trehalase (Treh) [15,32].
Consistent with repression of HNF4α, we detected low Alpi and
Mep1a transcript levels in the ileum of CF mice. Also, we observed a
strong reduction in the transcript levels of lactase (Lct), whereas tre-
halase (Treh) transcript levels were reduced to a more moderate extent
(Fig. 4A). In contrast, expression of other brush border disaccharidases,
i.e. maltase-glucoamylase (Mgam) and sucrose-isomaltase (Sis), was si-
milar in CF and wildtype mice. Further, we found that the expression of
the major monosaccharide transporters located in the brush border
membrane, GLUT5 (Slc2a5) and SGLT1 (Slc5a1), was similar in both
genotypes.
Of the major aminopeptidases, only glutamyl aminopeptidase
(Enpep) transcript levels showed a moderate reduction in the CF ileum,
compared to controls, whereas the expression of alanyl aminopeptidase
(Anpep) was not signiﬁcantly aﬀected (Fig. 4B). The expression of the
sodium-dependent amino acid transporters Slc6a19 and Slc6a20a
(SLC6A20) was modestly reduced in CF mice. No statistically signiﬁcant
diﬀerence was observed in the expression of the PEPT1 dipeptide
transporter (Slc15a1).
Intriguingly, we noted strong induction of Slc6a14, encoding a
broad-speciﬁcity amino acid transporter (ATB0,+), in the CF intestine:
whereas expression was negligible (< 1 RPKM) in ileum of controls,
this gene was robustly expressed in the ileum of CF mice (Fig. 4B). It has
been proposed that ATB0,+ is required for nitric oxide production in
inﬂamed tissue, as it facilitates cellular uptake of arginine, a substrate
of the inducible nitric oxide synthase (Nos2) [33]. Commensurate with
this hypothesis, we found that Nos2 transcript levels were also elevated
in CF mice, compared to controls (79.6 ± 9.9 vs. 22.3 ± 4.6 RPKM in
CF and control mice, respectively; P < .05, N=3). Consistent with an
altered host-microbe interaction, we also observed a strong induction of
Fut2 in CF ileum (7.4 ± 2.3 vs. 0.3 ± 0.04 RPKM in CF and control
mice, respectively; P < .05, N=3). This epithelial fucosyltransferase
plays a key role in host-microbe interactions, and is induced by bac-
terial colonization of the gut and, in particular, by LPS [34,35]. In-
creased Fut2 expression has been observed before in CF mice [36].
The ileum plays a crucial role in the enterohepatic circulation of bile
acids and cobalamin (vitamin B12). Therefore, we also investigated the
expression of plasma membrane proteins involved in the uptake of this
and other water-soluble vitamins, and of the apical sodium-dependent
bile acid transporter (Slc10a2). We found that transcript levels of Cubn,
which encodes the cobalamin receptor cubilin, were strongly (> 10-
fold) reduced in the CF ileum, compared to control tissue, whereas the
transcript levels of amnionless (Amn), which is also thought to be in-
volved in cobalamin uptake, were more moderately reduced (Fig. 4C).
Further, we observed a moderate reduction in the expression of the
sodium-dependent multivitamin transporter (Slc5a6), principally in-
volved in biotin and panthothenic acid uptake. The expression of the
pantetheine hydrolase ectoenzyme vanin-1 (Vnn1), a PPARα target
required for intraluminal production of panthothenic acid from its non-
absorbable precursors, was also markedly (> 3-fold) lower in the CF
ileum than in control tissue [37]. The expression of ascorbic and folic
acid transporters (Slc23a1 and Slc46a1, respectively) and of Slc10a2
was not aﬀected.
Finally, we assessed the expression of some major intestinal solute
transporters. These facilitate either sodium and chloride uptake via
proton (Slc9a3) and bicarbonate (Slc26a3, Slc26a6) antiport, respec-
tively, or mediate sulfate/citrate/succinate (Slc13a1/2), carnitine
(Slc22a5), nucleoside (Slc28a1/2) and phosphate (Slc34a2) uptake via
sodium symport. This analysis showed that transcript levels of the or-
ganic cation/carnitine transporter OCTN2 (Slc22a5) and the con-
centrative nucleoside transporter 1 (CNT1; Slc28a1) were signiﬁcantly
(ca. 2- and 20-fold, respectively) lower in CF than in control tissue
(Fig. 4D). The expression of the other solute transporters in this cate-
gory was not notably aﬀected, but expression of Pdzk1, encoding the
adaptor protein PDZK1 (NHERF3), was 4-fold lower in CF than in
control tissue. PDZK1 interacts with several solute transporters and
other proteins in (or at) the plasma membrane of intestinal epithelial
cells [38]. Most prominently, it is required for regulation of the sodium-
proton exchanger type 3 (NHE3/SLC9A3) and, consequently, sodium
absorption [38,39]. Transcript levels of another adaptor protein in-
volved in NHE3 regulation, Slc9a3r1 (NHERF1), were also lowered in
the CF ileum, albeit only to a moderate extent (< 2-fold). Similarly
modest reductions in transcript level were observed for Slc9a3r2
(NHERF2) and Pdzd3 (NHERF4).
3.5. Eﬀect of antibiotic treatment on intestinal gene expression in CF mice
Assuming that increased exposure of the intestinal epithelium to
bacterial endotoxins does indeed lead to repression of signaling through
RXR and other ligand-dependent nuclear receptors, we reasoned that
measures to counteract SIBO would restore their activity. To test this,
we treated animals with an antibiotic regimen that was previously
shown to reduce the bacterial load in CF while increasing community
diversity, leading to a convergence of the microbiome composition of
CF and wildtype mice [13]. While this regimen had a marked eﬀect on
ileal gene expression in both CF and wildtype mice, judging from the
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number of genes that were up- or down-regulated in the respective
genotypes, it had the largest impact in CF mice (Fig. 5A). Antibiotic
treatment (partially) corrected the expression of 331 genes out of a total
set of 370 that were consistently up- or down-regulated by a factor > 2
in CF compared to wildtype mice (Fig. 5B).
The URA was used to assess the eﬀect of antibiotic treatment on the
activation state of key inﬂammation modulators in the ileum of CF and
wildtype mice. This analysis showed that antibiotic treatment reduced
the activation state of typical inﬂammation modulators in both geno-
types, which indicates that these immune modulators also shape the
normal host response to the gut microbiota (Fig. 6A). In the CF ileum,
the antibiotic treatment reduced their activity to (or below) the levels
observed in conventionally reared wildtype mice (Fig. 6B). This sug-
gests that antibiotic treatment eﬀectively reduces bacterial numbers
and exposure to LPS, and attenuates the attendant immune response to
a level normally observed in the mouse intestine. Congruently, using
conventional RT-qPCR to assess gene expression in a larger cohort, we
found that after antibiotic treatment, transcript levels of typical in-
ﬂammation markers in CF mice and controls converge (Fig. S1).
Consistent with reduced LPS exposure, IPA indicated that the ac-
tivity of the LPS/IL1-mediated inhibition of RXR pathway was reduced
after antibiotic treatment (Z-score:−2.50, overlap P-value: 5.77·10−5),
and URA showed that the activation state of type II ligand-dependent
nuclear receptors tended to improve (Fig. 6C). This was also reﬂected
Fig. 4. Transcript levels of genes encoding proteins located at the apical plasma membrane of intestinal epithelial cells in the ileum of CF mice and controls. A.
Transcript level of genes encoding alkaline phosphatase, meprin1 and membrane proteins involved in the enzymatic release and uptake of monosaccharides. B.
Transcript level of genes encoding membrane proteins involved in the enzymatic release and uptake of oligopeptides and amino acids. C. Transcript level of genes
encoding membrane proteins involved in the uptake of vitamins and bile acids. D. Transcript level of genes encoding solute transporters and adaptor proteins
involved in the uptake of sodium, chloride, nucleosides, phosphate and sulfate. Data shown are mean ± SE of 3 animals per group (2F/1M). $:< 1 RPKM.
*P < .05;**P < .01 (Paired t-test). Gene symbols refer to the human orthologues.
Fig. 5. Eﬀect of antibiotic treatment on intestinal
gene expression in CF and wildtype mice. A. Venn
diagram representing the set of genes of which
transcript levels were increased or decreased> 2-
fold by antibiotic treatment in CF and/or wildtype
mice. B. Eﬀect of antibiotic treatment on the set of
genes that are up- or down-regulated in CF ileum by
a factor of> 2 in all 3 couples. Colored segments of
the pie charts represent the fraction of these diﬀer-
entially regulated genes that are up- or down-regu-
lated by antibiotic treatment by a factor > 1.5. The
deep-colored segments represent genes up- or down-
regulated by a factor > 2.
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by the fact that expression of most of the genes involved in lipid me-
tabolism that are controlled by such nuclear receptors was restored
(Fig. 6D).
We also noted that antibiotic treatment reversed the observed
changes in the expression of genes involved in the absorption of
monosaccharides, amino acids, nucleosides and B vitamins. Antibiotic
treatment strongly stimulated expression of Cubn, Lct, Slc6a20, Slc28a1
and Vnn1 in CF mice, and led to a more moderate induction of Alpi,
Mep1a, Pdzk1, Slc6a19, Slc9a3r1 and Treh (Fig. 6E). In contrast, Fut2,
Nos2 and Slc6a14 transcript levels were strongly reduced by antibiotic
treatment. In wildtype mice, antibiotic treatment had comparatively
little eﬀect on the expression of these genes, except for Nos2. Thus,
these data show that antibiotic treatment corrects many aspects of
anomalous gene expression in the CF ileum.
4. Discussion
In CF, intestinal dysbiosis is thought to be a key factor in the onset of
intestinal inﬂammation [2]. Presently, transcriptome analysis showed
unequivocal evidence for altered host-microbe interactions and the
activation of an innate and adaptive immune response in the distal
small intestine of a CF mouse model that is triggered by bacterial en-
dotoxins. Gut inﬂammation was associated with a marked overall re-
duction in the activity of type II ligand-dependent nuclear receptors,
which is predicted to strongly aﬀect fatty acid, sterol, bile acid and
xenobiotic metabolism and transport. Apart from these marked eﬀects
on lipid handling, we noted that CF is associated with reduced ex-
pression of genes involved in the absorption of other nutrients. Most of
these changes in gene expression could be corrected by antibiotic
treatment, suggesting that dysbiosis markedly aﬀects enterocyte ma-
turation in CF.
For the transcriptome analysis, congenic, sex-matched littermate
couples (Cftr N/N, Cftr−/−) were used, and each pair of animals was
housed together, to minimize bias due to environmental factors.
Conceivably because of this pairing strategy, the diﬀerences in gene
expression observed between CF and wildtype mice were remarkably
consistent between couples, albeit that the analysis is based on only a
limited number of animals. To further validate the data, we assessed
expression of a select number of genes by RT-qPCR in a larger cohort
and found the results to be in line with the RNAseq data (e.g. Fig. S1).
However, as both female and male couples were analyzed jointly, po-
tential sex-related diﬀerences in the response to Cftr deletion were not
accounted for.
Both IPA and GSEA indicated activation of the LPS receptor com-
plex, and T and B cell responses in the CF ileum. This signals the re-
cruitment and diﬀerentiation of immune cells in response to a microbial
challenge. These ﬁndings are in line with previous studies demon-
strating immune cell inﬁltration and SIBO in the CF gut [3–5]. A pre-
vious microarray analysis has also shown up-regulation of genes asso-
ciated with the innate immune response, but did not yield clear signs
Fig. 6. Eﬀect of antibiotic treatment on the expression of genes involved in the inﬂammatory response, lipid metabolism, and solute transport. A. The URA was used
to assess the activation state of inﬂammation modulators in antibiotic-treated CF and control mice, relative to conventionally reared animals of the same genotype. B.
The activation state of inﬂammation modulators in antibiotic-treated CF mice, relative to conventionally reared wildtype mice. For comparison, the activation state
in conventionally reared CF mice is included (data as in Table 1). C. Activation state of ligand-dependent nuclear receptors in CF mice, before and after antibiotic
treatment, compared to conventionally reared wildtype mice. D. Eﬀect of antibiotic treatment on the expression of genes involved in the metabolism and transport of
fatty acids, sterols, bile acids and xenobiotics (see Fig. 2A). Data depict transcript levels relative to conventionally reared animals of the same genotype. Gene symbols
refer to the human orthologues The horizontal, dotted line denotes a relative transcript level of 1 (no change). E. Eﬀect of antibiotic treatment on transcript levels of
genes encoding enzymes, solute transporters, receptors or adaptor proteins that are diﬀerentially regulated in CF mice and controls. Data depict transcript levels
relative to conventionally reared animals of the same genotype. Gene symbols refer to the human orthologues. The horizontal, dotted line denotes a relative
transcript level of 1 (no change). $: No transcript detected.
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for the development of an adaptive immune response [3]. Methodolo-
gical diﬀerences may underlie this disparity. Foremost, we exclusively
sampled the ileum (instead of the entire small intestine), which gen-
erally contains more bacteria than the proximal sections of the small
intestine and, consequently, may be more susceptible to inﬂammation.
Further, we employed a dietary regimen that avoided the use of a liquid
elemental diet and its inherent eﬀects on small intestinal bacterial
counts [8]. For similar reasons, mice were kept on normal drinking
water (without added osmolytes) as of several days before experi-
mentation. It has previously been shown that bacterial overgrowth is
readily diminished by application of a polyethylene glycol/electrolyte
drinking solution, probably because it accelerates intestinal transit
[40]. Of note, we found that this regimen did not fully normalize gene
expression in CF mice: the down-regulation of Cubn, the striking up-
regulation of Fut2 and Slc6a14, as well as the induction of inﬂammation
markers (e.g Ccl8, Saa1, Ubd) evident from the transcriptome dataset,
was also observed in CF mice that were not withheld laxative before
sampling (Fig. S2). This suggests that administration of polyethylene
glycol/electrolyte drinking solution does not correct dysbiosis com-
pletely. We speculate that in particular mucosa-attached communities
persist and modulate the host transcriptome [41].
The IPA indicated that signaling through type II ligand-dependent
nuclear receptors is markedly repressed in the CF intestine, as a con-
sequence of LPS/TLR-mediated activation of pro-inﬂammatory sig-
naling pathways that lead to repression of RXRα/β. LPS, a component
of the outer membrane of gram-negative bacteria, triggers the pro-
duction of pro-inﬂammatory cytokines by macrophages and other im-
mune cells by activation of the LPS receptor complex [42]. In liver, this
produces an acute phase response, which is characterized by distinct
changes in several major metabolic pathways that are largely controlled
by type II ligand-dependent nuclear receptors [18,43]. LPS and pro-
inﬂammatory cytokines were shown to cause NFκB-mediated transre-
pression of hepatic RXRα, and to decrease its nuclear levels [16–18]. In
addition, NFκB may tether FXR, leading to a comprehensive repression
of FXR-RXRα target genes [44,45]. The gut microbiota is known to
modulate the activity of FXR by intra-luminal conversion of primary
bile acids, which limits the level of FXR-antagonistic species, but may
also reduce uptake of the FXR-activating type [46,47]. Our data in-
dicate that dysbiosis, in addition, represses FXR through its eﬀects on
the host immune response.
RXRα/β heterodimer nuclear receptors play a key role in the me-
tabolism of fatty acids, sterols, bile acids and xenobiotics. Altered fatty
acid, sterol and bile acid transport and metabolism are typical of CF,
suggesting that intestinal repression of RXRα/β heterodimer nuclear
receptors contributes to the development of CF-related pathologies. For
instance, a deﬁciency of the intestinal FXR target FGF15/FGF19, or loss
of the receptor for this hormone (FGFR4), was shown to enhance fecal
excretion of bile acids, and to deplete the gall bladder, respectively
[48–51]. Similarly, the changes in the expression of genes involved in
intestinal lipid handling we present here may play a role in aberrant
fatty acid and cholesterol transport and the changes in tissue lipid
composition observed in CF patients and mouse models [52–57]. Re-
pression of RXRα/β may also contribute to the previously reported loss
of intestinal PPARγ activity in CF mice [7,58]. Interestingly, a reduction
in butyrate-producing obligate anaerobes was shown to attenuate
PPARγ signaling in mouse colon, leading to induction of Nos2 and re-
pression of fatty acid β-oxidation, i.e. metabolic changes that parallel
those observed presently in CF ileum [59]. The consequent increase in
nitrate production and decrease in oxygen consumption was proposed
to create a niche for facultative anaerobes, including pathogenic En-
terobacteriaceae.
Apart from these wide-ranging eﬀects on the expression of genes
involved in lipid handling, we also observed discrete changes in the
expression of genes involved in the absorption of monosaccharides,
amino acids, nucleosides and B vitamins. The most signiﬁcant changes
were observed in the transcript levels of Cubn, Lct, Pdzk1, Slc28a1 (all
markedly reduced in CF ileum). Lowered intestinal expression of Cubn,
Lct and Pdzk1 has been found in earlier transcriptome analyses on CF
mice [3,5], and lowered intestinal lactase, as well as alkaline phos-
phatase, levels have previously been reported for CF patients [60]. We
noted that the down-regulation of Cubn, Lct and Pdzk1 observed in the
CF ileum is reversed by antibiotic treatment, suggesting that the CF
microbiome also modulates the expression of these genes. It has been
shown that LPS-provoked acute endotoxemia reduces Cubn expression
in the kidney [61]. In CF mice, cubilin protein levels in the proximal
tubules were also reduced, resulting in a mild (low molecular weight)
proteinuria, but Cubn expression was apparently not aﬀected [62].
Down-regulation of PDZK1 (NHERF3) has been observed before in CF
mice, and in intestinal tissue of ulcerative colitis patients and murine
colitis models, suggesting that the expression of this gene is also con-
trolled by inﬂammation mediators [5,63]. Indeed, in Caco2-BBE cells,
IL-1β repressed PDZK1 expression [64]. Consistent with our present
data, the down-regulation of PDZK1 in this intestinal cell model may
result from repression of ligand-dependent nuclear receptor signaling,
as PPARα or RXRα activation was shown to ameliorate the eﬀect of IL-
1β on PDZK1 expression.
Up-regulation of intestinal SLC6A14 expression has previously been
reported for patients suﬀering from inﬂammatory bowel disease and for
Vibrio cholerae infected subjects, which suggests that the regulation of
this gene is also linked to host-microbe interactions and inﬂammation
[65,66]. In line with his notion, we found that antibiotic treatment
strongly repressed Slc6a14 expression in the CF ileum. Genome-wide
association studies on CF cohorts have shown that single nucleotide
polymorphisms at loci near the SLC6A14 gene are associated with
meconium ileus [67]. Although the functional consequences of this
polymorphism are unknown, it has been proposed that ATB0,+-medi-
ated uptake of arginine increases nitric oxide production in intestinal
epithelial cells and ameliorates the CF-typical ﬂuid secretory defect
[68]. This seems to imply that, perhaps contra intuitively, SIBO and a
consequent up-regulation of SLC6A14 improve luminal hydration in CF.
Expression of genes that encode proteins involved in nutrient pro-
cessing/uptake is particularly high in fully matured enterocytes, located
at or near the tips of the villi. Therefore, a reduction in the transcript
levels of these genes may signal an underlying defect in enterocyte
maturation [6]. Key aspects of enterocyte maturation, like formation of
the apical brush border and the expression of nutrient transporters,
were shown to be controlled by HNF4α in conjunction with CDX2 [69].
Consistent with impaired enterocyte maturation, URA indicated that
HNF4α is in an inactive state in the CF ileum. The set of down-regulated
HNF4α targets not only included genes encoding nutrient transporters,
but also those encoding proteins involved in host defense, like Alpi and
Mep1a [70,71]. Juxtaposed to HNF4α inactivation, URA and GSEA in-
dicated activation of c-Myc and E2F-type transcription factors, which
are linked to stem cell maintenance and cell cycle progression. While
this activation is indicative of immune cell inﬁltration, it is also con-
sistent with the observation that CF is associated with enhanced pro-
liferation of intestinal epithelial cells and expansion of the crypt com-
partment, as the expression of c-Myc and E2F target genes in epithelial
cells is reduced during crypt to villus diﬀerentiation [5,15,72,73]. In
mice, deletion of Hnf4a, similarly, leads to a subtle increase in intestinal
epithelial cell proliferation and crypt depth, suggesting that HNF4α
inactivation is inexorably linked to protracted activation of E2F-type
transcription factors [31]. Interestingly, Hnf4a null mice also display a
marked increase in small intestinal goblet cell numbers and a thick-
ening of the submucosae, i.e. a phenotype that mirrors aspects of the
intestinal CF pathology [5,31,72].
5. Conclusion
Transcriptome analysis indicated the activation of an innate and
adaptive immune response in the distal small intestine of a CF mouse
model. Inﬂammation was associated with diﬀerential regulation of
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numerous genes involved in the transport and metabolism of nutrients
and, in particular, lipids, that are targeted by type II ligand-dependent
nuclear receptors and/or HNF4α. Most changes in gene expression were
reversed by bacterial containment. These ﬁndings indicate that CF-re-
lated dysbiosis and the attendant immune response shape the en-
terocyte maturation program, providing new insights into the impact of
CF on intestinal epithelial cell dynamics, lipid metabolism and nutrient
absorption. Because these data indicate that dysbiosis and the attendant
intestinal inﬂammation contribute to the pathogenesis of CF-associated
defects in lipid metabolism and nutrient uptake, therapeutic interven-
tions aimed at containing or reversing SIBO and/or restoring the ac-
tivity of ligand-dependent nuclear receptors (e.g. by pharmacological
agonists) warrant consideration.
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